Akari Therapeutics Plc Quarterly Common Stock, Par or Stated Value Per Share in GBP/shares from Q3 2010 to Q4 2020

Taxonomy & unit
us-gaap: EUR/shares, GBP/shares, and USD/shares
Description
Face amount or stated value per share of common stock.
Summary
Akari Therapeutics Plc quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q3 2010 to Q4 2020.
  • Akari Therapeutics Plc Common Stock, Par or Stated Value Per Share for the quarter ending December 31, 2020 was 0.01 GBP/shares, unchanged year-over-year.
Common Stock, Par or Stated Value Per Share, Quarterly (GBP/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.